TORRANCE, California, 2 de febrero de 2024 /PRNewswire-HISPANIC PR WIRE/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), líder en el tratamiento de la anemia falciforme, también denominada enfermedad de células falciformes (ECF), acaba de anunciar que ha recibido la autorización de…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.